Repetitive Transcranial Magnetic Stimulation (Rtms / Tms) Research
by Joshua Parker on Jun 09, 2016
During the last 15 years, Professor Photios Anninos of Greece and neurologist Reuven Sandyk M.D. have been fabulously successful treating the neurological disorders Parkinson’s and Alzheimer’s using very weak AC magnetic fields transcranially.
We have found that pulsed DC electromagnetic fields have comparable effect but when used during the night produce a wide spectrum of synergistic effects. It is being discovered by researchers around the world that a host of beneficial biological effects appear to be triggered even where neurological and endocrine malfunction is a root cause of disease.
Research appears to be escalating into the neurological and psychological effects of repetitive transcranial magnetic stimulation (rTMS/TMS) that apply relatively strong pulsed electromagnetic fields to the brain and neuroendocrine system.
This type of therapy called repetitive transcranial magnetic stimulation (rTMS) or transcranial magnetic stimulation (TMS – or – sometimes called slow-TMS if 1 Hz or less – i.e. 1 pulse per second or less-) is gaining a strong reputation for being extremely safe and providing measurable and perceptible benefits in users. Though most therapeutic studies show TMS/rTMS provides safe, therapeutic effects warranting an explosion of research, widespread use of TMS/rTMS is strictly for diagnostic purposes. We have omitted most of these diagnostic studies from this resource.
Canada was close to approving rTMS / TMS for psychological / anti-depressive effects at 1000’s of Gauss magnetic field density, however it reversed its policy and is farther than ever from approval. Ludicrous, since the discovery by Anninos and Sandyk that picotesla fields (millions of times less dense @ 10-13 Tesla) than most rTMS have substantial neurological benefits.
In January ’07 the FDA Advisors rejected rTMS use for depression even though it does no harm and usually produces results.
Peer reviewed journal abstracts libraried by the National Institutes of Health (NIH) indicate rTMS / TMS as beneficial and without perceptible expected or unexpected adverse reactions in epilepsy, Parkinson’s disease, MS, Alzheimer’s, migraine headache, cluster headache, severe PMS, depression, ADD/ADHD and others.
Several hundred pulsed electromagnetic field therapy citations contained in our research bibliographies are linked directly to PubMed a service of the U.S. National Library of Medicine and the U.S. National Institutes of Health.
These studies are offered for your education only and are not intended as promotional material for Future Tech Today Inc.